← Leaderboards
Stephanos Kyrkanides
University Of Rochester
$3,175,841
Attributed
$3,175,841
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,330,321 · 8
By mechanism
P30$3,154,480 · 1
R21$1,451,196 · 4
R01$1,143,555 · 1
K08$501,340 · 1
R03$79,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Richard P. Phipps$12,624,990
- Alice P Pentland$5,682,476
Others in their field
Top investigators on “Beta N Acetylhexosaminidase”
- Miguel S Esteves · Massachusetts General Hospital$5,545,646
- Sunil K Chauhan · Schepens Eye Research Institute$2,189,224
- Stephen J Galli · Stanford University$2,014,857
- Patricia I Dickson · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$1,993,445
- Douglas R Martin · Auburn University At Auburn$1,959,815
- Eric Sjoberg · Orphi Therapeutics, Inc.$1,644,466
Research focus
Beta N AcetylhexosaminidaseLaboratory MouseGenetically Modified AnimalsGene TherapyBaseNeuronsGene TargetingTransfection /Expression VectorDisease /Disorder ModelEnzyme ActivityInflammatoryMouse ModelSandhoff DiseaseChronicNonhuman Therapy EvaluationLaboratoriesProgramsGene ExpressionInborn Lysosomal Enzyme DisorderInflammationMucopolysaccharidesGangliosidesCraniofacialCraniofacial Dysostosis
Grant awards (24)
Center for the Biologic Basis of Oral/Systemic Diseases (Phase III)$1,023,400
P30 · FY2018 · GM · contact PI
Center for the Biologic Basis of Oral/Systemic Diseases (Phase III)$1,051,995
P30 · FY2017 · GM · contact PI
Center for the Biologic Basis of Oral/Systemic Diseases (Phase III)$1,079,085
P30 · FY2016 · GM · contact PI
Neuro-inflammation and treatment in GM2 gangliosidosis$237,287
R01 · FY2007 · NS · contact PI
Joint degeneration: Somatic mosaic analysis in a transgenic mouse$176,118
R21 · FY2007 · DE · contact PI
Recombinant FIV vectors for the delivery of siRNA therapy to joints$164,487
R21 · FY2007 · AR · contact PI
Does peripheral localized chronic inflammation predispose to neurodegeneration?$154,943
R21 · FY2007 · AG · contact PI
Joint degeneration: Somatic mosaic analysis in a transgenic mouse$51,096
R21 · FY2007 · DE · contact PI
Neuro-inflammation and treatment in GM2 gangliosidosis$38,990
R01 · FY2007 · NS · contact PI
Does peripheral localized chronic inflammation predispose to neurodegeneration?$31,372
R21 · FY2007 · AG · contact PI
Neuro-inflammation and treatment in GM2 gangliosidosis$284,528
R01 · FY2006 · NS · contact PI
Recombinant FIV vectors for the delivery of siRNA therapy to joints$203,280
R21 · FY2006 · AR · contact PI
Joint degeneration: Somatic mosaic analysis in a transgenic mouse$195,000
R21 · FY2006 · DE · contact PI
Does peripheral localized chronic inflammation predispose to neurodegeneration?$159,900
R21 · FY2006 · AG · contact PI
Neuro-inflammation and treatment in GM2 gangliosidosis$291,375
R01 · FY2005 · NS
Neuro-inflammation and treatment in GM2 gangliosidosis$291,375
R01 · FY2004 · NS
Gene therapy for treatment of craniofacial dysplasia$157,500
R21 · FY2004 · DE
NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$125,335
K08 · FY2004 · DE
Gene therapy for treatment of craniofacial dysplasia$157,500
R21 · FY2003 · DE
NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$125,335
K08 · FY2003 · DE
NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$125,335
K08 · FY2002 · DE
NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$125,335
K08 · FY2001 · DE
ROLES OF NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$39,875
R03 · FY2001 · DE
ROLES OF NEURONAL FUNCTION IN CRANIOFACIAL DEVELOPMENT$39,875
R03 · FY2000 · DE